Institutional investors purchased a net $1.9 million shares of BIOS during the quarter ended September 2017 and now own 85.45% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Managed Health Care industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARES MANAGEMENT LLC Bought 6.3 Million shares of BioScrip Inc
MILLENNIUM MANAGEMENT LLC Bought 2.3 Million shares of BioScrip Inc
D. E. SHAW & CO. LP Bought 1.7 Million shares of BioScrip Inc